Weifeng ZHANG

Senior Director of Medical and Pharmacovigilance @ Alebund Pharmaceuticals

About

As a clinical development specialist with a background in neurology and a demonstrated history of working in the pharmaceutical industry, I have experience in both clinical development and pharmacovigilance across different therapeutic areas, including CNS, rare diseases, endocrinology, nephrology, and oncology. Inspired by Derek Lowe, I am authoring a newsletter about medicine and drug development in Chinese, called "MedNotes": https://mednotes.zhubai.love/

Country

China

City

Shanghai

Industry

Pharmaceuticals

Skill

Clinical Trials, Medical Affairs, Neurology, Diabetes, Key Opinion Leaders, Pharmaceutical Industry, Biotechnology

Experience

Senior Director of Medical and Pharmacovigilance

Alebund Pharmaceuticals

2024-7 - Present · 2 yrs 3 mos

Shanghai, China

Director of Pharmacovigilance

Alebund Pharmaceuticals

2022-4 - 2024-9 · 2 yrs 6 mos

Shanghai, China

I assumed responsibility for two areas: clinical science and pharmacovigilance. In clinical science, I managed the entire process of a clinical trial (AP306-HP-01), including trial design, protocol compilation, medical data monitoring, and CSR review. The investigational drug received a breakthrough designation in China based on the study results. In pharmacovigilance, I continued helping to complete and monitor the PV system establishment and operation.

Associate Director of Pharmacovigilance

Alebund Pharmaceuticals

2021-1 - 2022-3 · 1 yr 3 mos

Shanghai, China

Helped the company establish the pharmacovigilance (PV) system from scratch, covering operations and science. And took on practical tasks, including monitoring the PV process of the CRO, compiling Development Safety Update Reports, etc. In addition, developed the target product profile and the clinical trial protocol according to my personal development plan.

Associate Medical Director

Roche

2019-11 - 2021-1 · 1 yr 3 mos

Shanghai City, China

Proud of contributing to bring amyloid-beta PET tracers and CSF assays into China, which would be essential for clinical trials and practice. Provided scientific support to the pivotal studies of gantenerumab worldwide. Also took on the single contact person of prasinezumab for developing its clinical development plan in China.

Clinical Scientist

Roche

2018-9 - 2019-11 · 1 yr 3 mos

Shanghai City, China

Participated in the development of China-specific clinical development plans and the conduct of pivotal clinical trials of all molecules under the franchise of Neurodegeneration, including one molecule for the rare disease Huntington`s Disease.

Senior Central Safety Science Delivery Scientist

Roche

2018-1 - 2018-8 · 8 mos

Shanghai City, China

Proud of being a team member for the whole development of emicizumab, one groundbreaking treatment of hemophilia A, in China, from the development of its China-specific development plans to the NDA filing. Had experience on China Risk Management Plan (RMP) and the advisory board meeting conducted by the CDE. Also took on the owner of a cross-functional SOP.

Safety Scientist

Roche

2014-6 - 2017-12 · 3 yrs 7 mos

Shanghai City, China

Responsible for compiling pharmacovigilance dossiers and carrying out pharmacovigilance activities. Had experience working with study management teams as a safety representative and with local project teams for the clinical development plans of several molecules, including cobimetinib and emicizumab.

Medical Science Manager (Metabolics)

Bristol Myers Squibb

2012-12 - 2014-5 · 1 yr 6 mos

Shanghai City, China

Performed medical and brand strategies for the diabetic pipeline in China by proactive and effective engagement with therapeutic area experts. Provided comprehensive support to internal stakeholders.